Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Alteromonas macleodii Acetylglutamate kinase (argB) CSB-YP479006AZX
CSB-EP479006AZX
CSB-BP479006AZX
CSB-MP479006AZX
CSB-EP479006AZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alteromonas macleodii 10 kDa chaperonin (groS) CSB-YP479007AZX
CSB-EP479007AZX
CSB-BP479007AZX
CSB-MP479007AZX
CSB-EP479007AZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alteromonas macleodii Glycine--tRNA ligase beta subunit (glyS) CSB-YP479008AZX
CSB-EP479008AZX
CSB-BP479008AZX
CSB-MP479008AZX
CSB-EP479008AZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alteromonas macleodii 50S ribosomal protein L33 (rpmG) CSB-YP479009AZX
CSB-EP479009AZX
CSB-BP479009AZX
CSB-MP479009AZX
CSB-EP479009AZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii 50S ribosomal protein L9 (rplI) CSB-YP479010EYX
CSB-EP479010EYX
CSB-BP479010EYX
CSB-MP479010EYX
CSB-EP479010EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii Protein CrcB homolog (crcB), partial CSB-YP479011EYX1
CSB-EP479011EYX1
CSB-BP479011EYX1
CSB-MP479011EYX1
CSB-EP479011EYX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii Elongation factor P (efp) CSB-YP479012EYX
CSB-EP479012EYX
CSB-BP479012EYX
CSB-MP479012EYX
CSB-EP479012EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB) CSB-YP479013EYX
CSB-EP479013EYX
CSB-BP479013EYX
CSB-MP479013EYX
CSB-EP479013EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP479014EYX
CSB-EP479014EYX
CSB-BP479014EYX
CSB-MP479014EYX
CSB-EP479014EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii 30S ribosomal protein S15 (rpsO) CSB-YP479015EYX
CSB-EP479015EYX
CSB-BP479015EYX
CSB-MP479015EYX
CSB-EP479015EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii N utilization substance protein B homolog (nusB) CSB-YP479016EYX
CSB-EP479016EYX
CSB-BP479016EYX
CSB-MP479016EYX
CSB-EP479016EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii Probable GTP-binding protein EngB (engB) CSB-YP479017EYX
CSB-EP479017EYX
CSB-BP479017EYX
CSB-MP479017EYX
CSB-EP479017EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii 30S ribosomal protein S5 (rpsE) CSB-YP479018EYX
CSB-EP479018EYX
CSB-BP479018EYX
CSB-MP479018EYX
CSB-EP479018EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii Leucine--tRNA ligase (leuS) CSB-YP479019EYX
CSB-EP479019EYX
CSB-BP479019EYX
CSB-MP479019EYX
CSB-EP479019EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii 30S ribosomal protein S19 (rpsS) CSB-YP479020EYX
CSB-EP479020EYX
CSB-BP479020EYX
CSB-MP479020EYX
CSB-EP479020EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii 30S ribosomal protein S12 (rpsL) CSB-YP479021EYX
CSB-EP479021EYX
CSB-BP479021EYX
CSB-MP479021EYX
CSB-EP479021EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii Riboflavin biosynthesis protein ribBA (ribBA) CSB-YP479022EYX
CSB-EP479022EYX
CSB-BP479022EYX
CSB-MP479022EYX
CSB-EP479022EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP479023EYX1
CSB-EP479023EYX1
CSB-BP479023EYX1
CSB-MP479023EYX1
CSB-EP479023EYX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii Arginine--tRNA ligase (argS) CSB-YP479024EYX
CSB-EP479024EYX
CSB-BP479024EYX
CSB-MP479024EYX
CSB-EP479024EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prosthecochloris aestuarii 60 kDa chaperonin (groL), partial CSB-YP479025EYX
CSB-EP479025EYX
CSB-BP479025EYX
CSB-MP479025EYX
CSB-EP479025EYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>